Health Behavior Change in High-Risk Colorectal Cancer Individuals
Facilitating Health Behavior Change in High-Risk Individuals for Colorectal Cancer: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Background Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challenging. This study aims to test a comprehensive support program designed to help high-risk individuals make and sustain these positive health behavior changes. Purpose The main goal of this research is to see if a specially designed 12-week health promotion program can effectively help high-risk individuals improve their lifestyle (e.g., diet, exercise, smoking/alcohol use), increase their knowledge about colorectal cancer, and strengthen their confidence and motivation to stay healthy. Study Groups Participants in this study will be randomly assigned (like flipping a coin) to one of two groups:
- Educational Workshops: Five in-person group sessions to learn about cancer prevention, create personal health plans, and solve problems with others.
- Online Support: Regular health articles and tips sent through a private WeChat group.
- Daily Check-ins: Using the WeChat group for simple daily check-ins on exercise, fruit/vegetable intake, and smoking/alcohol use to build habit.
- Peer Support: Being paired with a "health buddy" and interacting with other participants for motivation. All participants will be asked to complete several questionnaires at the beginning of the study, during the program, and after it ends (at 3 months) to measure their knowledge, beliefs, and lifestyle habits. Duration The active program lasts for 12 weeks. Potential Benefits Participants in the Intervention Group may benefit from improved health habits, a better understanding of how to reduce their cancer risk, and increased social support. Participants in the control group will receive general health information. If they wish, they will receive the same health materials and behavioral change intervention as the intervention group after the intervention concludes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2026
CompletedDecember 4, 2025
November 1, 2025
3 months
November 19, 2025
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Score change in the Health Promotion Lifestyle Scale for High-Risk Colorectal Cancer Population (HPLP-HRCP)
This is the primary outcome measure, assessed using the revised Health Promotion Lifestyle Profile for High-Risk Colorectal Cancer Population (HPLP-HRCP). This scale measures the level of health-promoting lifestyle behaviors. A higher total score indicates a better health-promoting lifestyle.
Baseline (Week 0), Post-intervention (Week 12)
Secondary Outcomes (5)
Score change in Colorectal Cancer Knowledge Questionnaire (CRC-KQ)
Baseline (Week 0), Post-intervention (Week 12).
Score change in the Champion Health Belief Model Scale (CHBMS)
Baseline (Week 0), Post-intervention (Week 12).
Score change in the Multidimensional Health Locus of Control Scale (MHLC)
Baseline (Week 0), Post-intervention (Week 12).
Score change in the Kessler Psychological Distress Scale (K10)
Baseline (Week 0), Post-intervention (Week 12).
Score change in the Perceived Social Support Scale (PSSS)
Baseline (Week 0), Post-intervention (Week 12).
Study Arms (2)
Health Promotion Lifestyle Intervention Group
EXPERIMENTALParticipants in this arm receive a 12-week, multi-component health promotion program based on the Health Promotion Model. The intervention includes: 1) Five in-person group workshops focusing on knowledge, motivation, planning, and maintenance; 2) Online support via a WeChat group for daily behavioral check-ins (e.g., exercise, diet) and peer support; 3) Educational articles and resources; 4) Techniques from Motivational Interviewing and Acceptance and Commitment Therapy to foster psychological adjustment and behavior change.
Standard Care
ACTIVE COMPARATORParticipants in this arm receive standard care, which may include general health information about colorectal cancer prevention. They do not participate in the structured workshops, online check-ins, or specialized support of the experimental intervention. They will complete all the same assessment questionnaires as the intervention group. They may be offered the intervention program after the study is complete (wait-list design).
Interventions
1. Intervention Name: Multi-Component Health Promotion Lifestyle Intervention 2. Description: This is a structured, theory-based intervention designed to facilitate health behavior change in individuals at high risk for colorectal cancer. It is distinguished by its foundation in the Health Promotion Model and the Integrative Model of Health Behavior Change, and its use of a blended online and offline delivery model over a 12-week period. The intervention is organized into five sequential modules: Cognitive Reconstruction: Provides essential knowledge about colorectal cancer (etiology, risk factors) and disease prevention strategies. Psychological Adjustment: Employs techniques from Motivational Interviewing to build intrinsic motivation and Acceptance and Commitment Therapy (ACT) to help participants manage distress and psychological barriers related to their cancer risk. Health Behavior Establishment: Guides participants in creating personalized health plans and builds self-effic
Participants randomised to the control arm will receive standard care, which may include general health advice or publicly available educational pamphlets on colorectal cancer prevention. They will not receive any component of the structured multi-component health promotion lifestyle intervention (i.e., no group workshops, no WeChat-based check-ins, no psychological techniques training, and no facilitated peer support). However, they will be asked to complete all the same assessment questionnaires at the same time points as the intervention group. Upon completion of the final follow-up assessment, participants in this arm will be offered the opportunity to receive the full intervention program (wait-list design).
Eligibility Criteria
You may qualify if:
- Meets the criteria for being at high-risk for colorectal cancer as defined by the US National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening and the relevant Chinese expert consensus on colorectal cancer diagnosis and treatment.
- Age ≥ 18 years.
- Has normal verbal communication and comprehension abilities.
- Provides informed consent and voluntarily agrees to participate in the study.
You may not qualify if:
- Has a prior diagnosis of any malignancy (cancer).
- Has a diagnosed severe psychiatric or psychological disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Nursing, China Medical University
Shenyang, Liaoning, 110122, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Researcher, School of Nursing, China Medical University
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 4, 2025
Study Start
November 10, 2025
Primary Completion
February 10, 2026
Study Completion
February 10, 2026
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
What IPD will be shared? Individual participant data that underlie the results reported in the primary and secondary publications after de-identification. This will include demographic data, baseline characteristics, and all outcome measure scores (e.g., HPLP-HRCP, CRC-KQ, CHBMS, MHLC, K10, PSSS). When will IPD be available? Beginning 9 months after the publication of the main trial results and ending 36 months thereafter. Who can access the IPD?? Researchers who provide a methodologically sound proposal for use in an independent ethical review-approved meta-analysis or replication study. How can IPD be accessed? Proposals should be directed to the corresponding author via email. To gain access, requestors will need to sign a data access agreement. Data will be shared via a secure file transfer platform. What other documents will be available? The study protocol, statistical analysis plan, and informed consent form will be made available on ClinicalTrials.gov alongside the results.